"omega-N-Methylarginine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A competitive inhibitor of nitric oxide synthetase.
| Descriptor ID |
D019323
|
| MeSH Number(s) |
D12.125.068.050.650 D12.125.095.104.650 D12.125.142.087.500
|
| Concept/Terms |
omega-N-Methylarginine- omega-N-Methylarginine
- omega N Methylarginine
- NG-Monomethyl-L-Arginine
- NG Monomethyl L Arginine
- L-NMMA
- L-Monomethylarginine
- L Monomethylarginine
- N(G)-Monomethylarginine
- D-NMMA
- N(G)-Monomethyl-D-Arginine
- N(omega)-Monomethyl-L-Arginine
- L-NG-Monomethyl Arginine
- Arginine, L-NG-Monomethyl
- L NG Monomethyl Arginine
- N(G)-Methylarginine
|
Below are MeSH descriptors whose meaning is more general than "omega-N-Methylarginine".
Below are MeSH descriptors whose meaning is more specific than "omega-N-Methylarginine".
This graph shows the total number of publications written about "omega-N-Methylarginine" by people in this website by year, and whether "omega-N-Methylarginine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "omega-N-Methylarginine" by people in Profiles.
-
Yen W, Cai B, Yang J, Zhang L, Zeng M, Tarbell JM, Fu BM. Endothelial surface glycocalyx can regulate flow-induced nitric oxide production in microvessels in vivo. PLoS One. 2015; 10(1):e0117133.
-
Kang H, Cancel LM, Tarbell JM. Effect of shear stress on water and LDL transport through cultured endothelial cell monolayers. Atherosclerosis. 2014 Apr; 233(2):682-690.
-
Kato GJ, Wang Z, Machado RF, Blackwelder WC, Taylor JG, Hazen SL. Endogenous nitric oxide synthase inhibitors in sickle cell disease: abnormal levels and correlations with pulmonary hypertension, desaturation, haemolysis, organ dysfunction and death. Br J Haematol. 2009 May; 145(4):506-13.
-
Kenney MJ, Weiss ML, Mendes T, Wang Y, Fels RJ. Role of paraventricular nucleus in regulation of sympathetic nerve frequency components. Am J Physiol Heart Circ Physiol. 2003 May; 284(5):H1710-20.
-
Villalta F, Zhang Y, Bibb KE, Kappes JC, Lima MF. The cysteine-cysteine family of chemokines RANTES, MIP-1alpha, and MIP-1beta induce trypanocidal activity in human macrophages via nitric oxide. Infect Immun. 1998 Oct; 66(10):4690-5.
-
Hayashi T, Fukuto JM, Ignarro LJ, Chaudhuri G. Gender differences in atherosclerosis: possible role of nitric oxide. J Cardiovasc Pharmacol. 1995 Nov; 26(5):792-802.
-
Farias-Eisner R, Sherman MP, Aeberhard E, Chaudhuri G. Nitric oxide is an important mediator for tumoricidal activity in vivo. Proc Natl Acad Sci U S A. 1994 Sep 27; 91(20):9407-11.
-
Vargas HM, Cuevas JM, Ignarro LJ, Chaudhuri G. Comparison of the inhibitory potencies of N(G)-methyl-, N(G)-nitro- and N(G)-amino-L-arginine on EDRF function in the rat: evidence for continuous basal EDRF release. J Pharmacol Exp Ther. 1991 Jun; 257(3):1208-15.
-
Ross G, Chaudhuri G, Ignarro LJ, Chyu KY. Acetylcholine vasodilation of resistance vessels in vivo may not entirely depend on newly synthesized nitric oxide. Eur J Pharmacol. 1991 Mar 26; 195(2):291-3.
-
Vargas HM, Ignarro LJ, Chaudhuri G. Physiological release of nitric oxide is dependent on the level of vascular tone. Eur J Pharmacol. 1990 Nov 13; 190(3):393-7.